Home/Filings/4/0001013594-25-000764
4//SEC Filing

Paulson John 4

Accession 0001013594-25-000764

CIK 0000885590other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:44 PM ET

Size

5.5 KB

Accession

0001013594-25-000764

Insider Transaction Report

Form 4
Period: 2025-06-13
Paulson John
Director
Transactions
  • Purchase

    Common Stock, no par value

    2025-06-13$5.94/sh+3,564,059$21,170,51032,791,702 total(indirect: By Managed Funds)
Footnotes (1)
  • [F1]John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.

Documents

1 file

Issuer

Bausch Health Companies Inc.

CIK 0000885590

Entity typeother

Related Parties

1
  • filerCIK 0001394923

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:44 PM ET
Size
5.5 KB